BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 31232017)

  • 1. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
    Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients.
    Yao C; Li G; Cai M; Qian Y; Wang L; Xiao L; Thaiss F; Shi B
    Cancer Biomark; 2017 Jul; 20(1):23-29. PubMed ID: 28759952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma.
    Zhang X; Li W; Li S; Zhang Z; Song W
    Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.
    Hoan NX; Van Tong H; Giang DP; Cuong BK; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Song LH; Velavan TP
    Oncotarget; 2017 Mar; 8(10):17127-17139. PubMed ID: 28179578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases.
    Zhang Y; Xi H; Nie X; Zhang P; Lan N; Lu Y; Liu J; Yuan W
    Curr Drug Metab; 2019; 20(10):785-798. PubMed ID: 31608838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
    Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
    Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF
    PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
    Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.